165 related articles for article (PubMed ID: 17630861)
1. Commentary by an academic child psychiatrist on the relationship of the pharmaceutical industry, academia, psychiatric practice, and the Food and Drug Administration.
Varley CK
J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):292-4. PubMed ID: 17630861
[No Abstract] [Full Text] [Related]
2. Commentary by an academic child and adolescent psychiatrist.
Riddle MA
J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):300-2. PubMed ID: 17630863
[No Abstract] [Full Text] [Related]
3. Commentary by a child psychiatrist practicing in a community setting.
Burke MG
J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):295-9. PubMed ID: 17630862
[No Abstract] [Full Text] [Related]
4. Partnerships between academic psychiatry and the pharmaceutical industry: the Lilly MAP Initiative.
Singh B; Copolov D; Grainger D; Goh J
Australas Psychiatry; 2004 Sep; 12(3):220-4; discussion 225-6. PubMed ID: 15715778
[TBL] [Abstract][Full Text] [Related]
5. Uneasy alliance--clinical investigators and the pharmaceutical industry.
Bodenheimer T
N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
[No Abstract] [Full Text] [Related]
6. Translation of cancer immunotherapies.
Mulé JJ; Weber JS
Nat Med; 2004 Nov; 10(11):1153; author reply 1153-4. PubMed ID: 15516900
[No Abstract] [Full Text] [Related]
7. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
Tobbell DA
Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
[TBL] [Abstract][Full Text] [Related]
8. Co-opting psychiatry: the alliance between academic psychiatry and the pharmaceutical industry.
Moncrieff J
Epidemiol Psichiatr Soc; 2007; 16(3):192-6. PubMed ID: 18020190
[TBL] [Abstract][Full Text] [Related]
9. Accelerating identification and regulatory approval of investigational cancer drugs.
Esserman LJ; Woodcock J
JAMA; 2011 Dec; 306(23):2608-9. PubMed ID: 22187281
[No Abstract] [Full Text] [Related]
10. Clinical investigators and the pharmaceutical industry.
Newman TJ
N Engl J Med; 2000 Aug; 343(7):510-1. PubMed ID: 10950675
[No Abstract] [Full Text] [Related]
11. Academic medical centers and the pharmaceutical industry.
Del Parigi A
Clin Pharmacol Ther; 2010 Oct; 88(4):464-5. PubMed ID: 20703224
[No Abstract] [Full Text] [Related]
12. Too friendly? Teaching hospitals revisit ties to pharmaceutical firms.
Romano M
Mod Healthc; 2003 Jul; 33(28):17. PubMed ID: 12884711
[No Abstract] [Full Text] [Related]
13. Collaborating with industry--choices for the academic medical center.
Moses H; Braunwald E; Martin JB; Thier SO
N Engl J Med; 2002 Oct; 347(17):1371-5. PubMed ID: 12397200
[No Abstract] [Full Text] [Related]
14. Cancer immunotherapy: breaking the barriers to harvest the crop.
Pardoll D; Allison J
Nat Med; 2004 Sep; 10(9):887-92. PubMed ID: 15340404
[TBL] [Abstract][Full Text] [Related]
15. Biomedicine and industry.
MD; 1982 May; 26(6):117-9, 122, 126-7 passim. PubMed ID: 10255302
[No Abstract] [Full Text] [Related]
16. Poor reports dog industry-academia liaison.
Ready T
Nat Med; 2002 Dec; 8(12):1338-9. PubMed ID: 15085880
[No Abstract] [Full Text] [Related]
17. Few US medical schools and medical centres are disclosing industry ties.
Tanne JH
BMJ; 2010 Feb; 340():c1075. PubMed ID: 20179129
[No Abstract] [Full Text] [Related]
18. Is academic medicine for sale?
Lebowitz J
N Engl J Med; 2000 Aug; 343(7):509; author reply 510. PubMed ID: 10950673
[No Abstract] [Full Text] [Related]
19. Role of Leaders in Fostering Meaningful Collaborations Between Academic Medical Centers and Industry While Also Managing Individual and Institutional Conflicts of Interest.
Pizzo PA; Lawley TJ; Rubenstein AH
JAMA; 2017 May; 317(17):1729-1730. PubMed ID: 28464157
[No Abstract] [Full Text] [Related]
20. The unhealthy alliance between academia and corporate America.
Andreopoulos S
West J Med; 2001 Oct; 175(4):225-6. PubMed ID: 11577038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
